SESSION 3: GOALS OF AND APPROACHES TO BIOETHICS EDUCATION
DR. WAGNER: I believe we have everybody in the room, so let's get underway.
We're turning our attention now to the goals of and approaches to bioethics education and we will follow the same format, introducing you one by one, asking for your statements, and then when we get through, we will enjoy conversation with you.
SESSION 1: CONNECTING DEMOCRATIC DELIBERATION THEORY TO PRACTICE
DR. WAGNER: So I ask Drs. Fishkin and Kim, please, to join us at the table here. We're going to dive into our work on deliberation and bioethics education. And this panel is focused on "Connecting Democratic Deliberation Theory to Practice."
In our usual format, we will ask, gentlemen, to hear from each of you. And we will hold questions until both of you have had a chance to make your presentations.
SESSION 2: DEMOCRATIC DELIBERATION IN BIOETHICS
DR. GUTMANN: Welcome back, everybody. I'm sure our other Commission members will appear momentarily, so I'm just going to get started. We are going to continue our discussion of the role of deliberation in bioethics, and we have two distinguished speakers.
DR. GUTMANN: Good morning, everybody. I'm Amy Gutmann and I Chair the Presidential Commission for the Study of Bioethical Issues and I also am the President of the University of Pennsylvania and I'm very pleased to welcome you all here in the new Henry Jordan Medical Education Center at our Perelman School of Medicine. I'm also pleased on behalf of myself and our Vice Chair, Jim Wagner, to welcome you to our 21st meeting of the Bioethics Commission.
University of Pennsylvania
Henry Jordan Medical Education Center
5th Floor Lobby
3400 Civic Center Boulevard
Wednesday, May 27
9:00 – 9:15 a.m. Welcome and Opening Remarks
Amy Gutmann, Ph.D.
James Wagner, Ph.D.
Commission Vice Chair
9:15 – 9:45 a.m. Reflections in Memory of John D. Arras
SESSION 7: MEMBER DISCUSSION
DR. GUTMANN: Other ‑‑ we're going to move on to Ebola, from the brain to Ebola. Okay? Okay.
SESSION 6: MEMBER DISCUSSION
DR. GUTMANN: Good morning, everyone. I'm Amy Gutmann, I'm president of the University of Pennsylvania, and have the privilege of chairing the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and my vice chair, our vice chair, Jim Wagner, the president of Emory University, I would like to welcome you back to the second day of our 20th meeting.
Let me begin by noting the presence of our designated federal official, Bioethics Commission Executive Director Lisa M. Lee. Lisa, welcome.
SESSION 5: ROUNDTABLE DISCUSSION
DR. GUTMANN: Well, first of all, welcome back. By unanimous agreement among the commission, we had the best group of presenters today, bar none, so that means that our expectations are very high for this final panel.
I always ask one question and go down and ask you all to give one succinct answer to it, and then we'll open up.
SESSION 4: HISTORICAL, SOCIOLOGICAL, AND LEGAL PERSPECTIVES ON U.S. POLICIES INTENDED TO PREVENT EBOLA IN THE UNITED STATES
DR. WAGNER: This is the final panel of today, and it's to discuss the historical and sociological and legal perspectives on U.S. policies that are intended to prevent Ebola in the United States. Our first speaker will be Dr. Howard Markel who is the George E. Wantz distinguished professor of the history of medicine and the founding director of the Center for the History of Medicine at the University of Michigan.
SESSION 3: HOW U.S. PUBLIC ATTITUDES AND POLICIES INTENDED TO PREVENT EBOLA IN THE UNITED STATES IMPACT AFFECTED COMMUNITIES
DR. GUTMANN: Welcome, everybody. Welcome back. This is our third panel for the day and the first two panels were terrific and I’m sure this one will be as well.
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply